was amplified by PCR using a reverse primer introducing the point mutation G>C at position nt 839. The PCR product was then inserted in the corresponding KpnI and TfiI of pc-STAC3-GFP. 
727-1080). The two separate PCR products were fused in a SOE-PCR reaction. Finally, the SOE-PCR fragment and pc-STAC2-GFP were BspEI and BamHI digested and subsequently ligated.
pc-STAC3/STAC2-GFP.
The N-terminal part of STAC3, containing the poly-E and the PKC-C1 domains, was inserted into the respective position of STAC2 by SOE-PCR as follows. The N-terminal region (nt 1-736) of STAC3 was isolated from pc-STAC3-GFP, while the C-terminal part of STAC2 (nt 865-1224), containing the two SH3 domains, was isolated from pc-STAC2-GFP. The two separate PCR products were fused in a SOE-PCR reaction. Finally, the SOE-PCR fragment and pc-STAC2-GFP were KpnI and BamHI digested and subsequently ligated.
pc-STAC2-polyE-GFP. The N-terminal part of STAC3, containing the poly-E region, was inserted into the respective position of STAC2 by SOE-PCR as follows. The N-terminal region (nt 1-274) of STAC3 was isolated from pc-STAC3-GFP, while the C-terminal part of STAC2 (nt 331-1224), containing the PKC-C1 and the two SH3 domains was isolated from pc-STAC2-GFP. The two separate PCR products were fused in a SOE-PCR reaction. Finally, the SOE-PCR fragment and pc-STAC2-GFP were KpnI and BamHI digested and subsequently ligated. 
pc-STAC3-GFP point mutants (K98R, P99A, K100S, F101P, D103E, V104L, M108L, I126V, Y133E).
Briefly the cDNA sequence of STAC3 (nt 1-1080) was PCR amplified in separate PCR reactions using pc-STAC3-GFP as template with overlapping primers mutating the amino acid of interest. The two separate PCR products were then used as templates for a PCR reaction with flanking primers to connect the nucleotide sequences. The resulting fragment was then KpnI/BamHI digested and ligated into the corresponding sites of pc-STAC3-GFP.
pc-STAC3-V104L/Y133E-GFP.
The cDNA sequence of STAC3-V104L (nt 1-1080) was PCR amplified in separate PCR reactions using pc-STAC3-V104L-GFP as template with overlapping primers introducing the mutation T>G and C>A at positions 397 and 399. The two separate PCR products were then used as templates for a PCR reaction with flanking primers to connect the nucleotide sequences. The resulting fragment was then KpnI/BamHI digested and ligated into the corresponding sites of pc-STAC3-GFP.
Sequence integrity of the all newly generated constructs was confirmed by sequencing (MWG Biotech, Martinsried, Germany). Fig. S1 . FRAP analysis of STAC3-GFP in dysgenic myotubes. STAC3-GFP expressed without an Ca V  1 subunit in dysgenic myotubes is diffusely distributed and its fluorescence recovers within few seconds after photobleaching (mean±SE, N=3 n=12), similar to Ca V  subunits 2 (upper bar, 10 m; lower bar, 1m). in the large majority of myotubes (98.3±1.0% and 73.3±4.9%, respectively; N=4, n=120). Color overlay:
Supplementary Figures
4X of blue rectangle. Scale bars: 10 μm and 5 μm.
